Trimport
by Gerard Medical Enterprises, Inc. 2 variants
510(k) K945250
Active
Valid until
No expiry
FDA recalls
None ongoingDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK945250 | Date7 Mar 1995 | StatusActive |
Recalls
-
- Terminated Z-1882-2010
- Terminated Z-1886-2010
- Terminated Z-1885-2010
- Terminated Z-1887-2010
- Terminated Z-1881-2010
- Terminated Z-1883-2010
- Terminated Z-1884-2010
FDA testing determined that non-coring needles included in the Vaxcel Port and Vaxcel Port with PASV Valve may result in coring and resulting septum damage which could lead to patient injury.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- LJT
- Device Class
- Class II
- Regulation
- 21 CFR Part 880.5965
- Advisory Committee
- General Hospital
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 1 Oct 2026
The TrimPort Implantable Access System is a subcutaneous, implanted port and catheter device designed for intravascular access. It facilitates repeated vascular access for parenteral administration of fluids and blood withdrawal, serving as a long-term solution for patients requiring frequent intravenous therapies or sampling.
This device is supplied sterile and intended for single-use implantation. It is classified under product code LJT and falls under FDA 510(k) clearance (K945250) as substantially equivalent to the predicate device. The system is intended for use in general hospital settings and adheres to regulatory requirements outlined under 880.5965. No MRI safety information or reusable specifications are indicated in the data.
Other devices from Gerard Medical Enterprises, Inc.
Questions
AI-generated answers, 1 Oct 2026
What is the TrimPort Implantable Access System used for?
The TrimPort Implantable Access System is designed for repeated intravascular access, enabling the parenteral administration of fluids and blood withdrawal. It serves as a long-term solution for patients requiring frequent intravenous therapies or blood sampling, providing reliable and convenient access without repeated needle insertions.
Is the TrimPort supplied sterile and intended for single-use?
Yes, the TrimPort is supplied sterile and is intended for single-use implantation. This ensures patient safety by minimizing the risk of infection and contamination associated with reusable devices.
What type of medical facility is the TrimPort intended for?
The TrimPort is classified under product code LJT and is intended for use in general hospital settings. Its design and regulatory compliance align with standards for devices used in clinical environments requiring sterile, long-term vascular access.
Does the TrimPort have any MRI safety information?
The provided data does not include any specific MRI safety information for the TrimPort Implantable Access System. Patients or clinicians should consult the manufacturer’s instructions or additional documentation for MRI-related precautions before use.
What regulatory pathway does the TrimPort follow?
The TrimPort Implantable Access System follows the FDA 510(k) clearance pathway, specifically classified as substantially equivalent to a predicate device under the FDA’s regulations. It holds clearance number K945250 and adheres to regulatory requirements outlined under 880.5965.